Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China.
Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, 710061, P. R. China.
Cancer Commun (Lond). 2021 Nov;41(11):1183-1194. doi: 10.1002/cac2.12207. Epub 2021 Aug 16.
Breast cancer is the most commonly diagnosed cancer and leading cause of cancer death among women worldwide but has patterns and trends which vary in different countries. This study aimed to evaluate the global patterns of breast cancer incidence and mortality and analyze its temporal trends for breast cancer prevention and control.
Breast cancer incidence and mortality data in 2020 were obtained from the GLOBOCAN online database. Continued data from the Cancer Incidence in Five Continents Time Trends, the International Agency for Research on cancer mortality and China National Central Cancer Registry were used to analyze the time trends from 2000 to 2015 through Joinpoint regression, and annual average percent changes of breast cancer incidence and mortality were calculated. Association between Human Development Index and breast cancer incidence and mortality were estimated by linear regression.
There were approximately 2.3 million new breast cancer cases and 685,000 breast cancer deaths worldwide in 2020. Its incidence and mortality varied among countries, with the age-standardized incidence ranging from the highest of 112.3 per 100,000 population in Belgium to the lowest of 35.8 per 100,000 population in Iran, and the age-standardized mortality from the highest of 41.0 per 100,000 population in Fiji to the lowest of 6.4 per 100,000 population in South Korea. The peak age of breast cancer in some Asian and African countries were over 10 years earlier than in European or American countries. As for the trends of breast cancer, the age-standardized incidence rates significantly increased in China and South Korea but decreased in the United States of America (USA) during 2000-2012. Meanwhile, the age-standardized mortality rates significantly increased in China and South Korea but decreased in the United Kingdom, the USA, and Australia during 2000 and 2015.
The global burden of breast cancer is rising fast and varies greatly among countries. The incidence and mortality rates of breast cancer increased rapidly in China and South Korea but decreased in the USA. Increased health awareness, effective prevention strategies, and improved access to medical treatment are extremely important to curb the snowballing breast cancer burden, especially in the most affected countries.
乳腺癌是全世界最常见的癌症,也是女性癌症死亡的主要原因,但在不同国家,其发病模式和趋势有所不同。本研究旨在评估全球乳腺癌发病率和死亡率的模式,并分析其时间趋势,以进行乳腺癌的预防和控制。
从 GLOBOCAN 在线数据库中获取 2020 年乳腺癌发病和死亡数据。利用癌症发病率在五大洲的时间趋势、国际癌症研究机构癌症死亡率和中国国家癌症中心登记处的数据,通过 Joinpoint 回归分析 2000 年至 2015 年的时间趋势,计算乳腺癌发病率和死亡率的年平均变化百分比。采用线性回归分析人类发展指数与乳腺癌发病率和死亡率的关系。
2020 年全球约有 230 万例新发乳腺癌病例和 68.5 万例乳腺癌死亡病例。各国的发病率和死亡率存在差异,年龄标准化发病率从比利时的 112.3/10 万到伊朗的 35.8/10 万不等,年龄标准化死亡率从斐济的 41.0/10 万到韩国的 6.4/10 万不等。一些亚洲和非洲国家乳腺癌的发病高峰年龄比欧洲或美洲国家早 10 年以上。就乳腺癌的趋势而言,2000-2012 年期间,中国和韩国的年龄标准化发病率显著上升,而美国则下降。与此同时,2000 年至 2015 年期间,中国和韩国的年龄标准化死亡率显著上升,而英国、美国和澳大利亚的死亡率则下降。
全球乳腺癌负担增长迅速,且在各国之间存在巨大差异。中国和韩国的乳腺癌发病率和死亡率迅速上升,而美国则下降。提高健康意识、采取有效的预防策略和改善医疗服务的可及性对于遏制乳腺癌负担的不断增加至关重要,特别是在受影响最严重的国家。